Evidence map›Paper›PMID 23455501›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency.

John T Bates, Christopher J Keefer, Thomas J Utley, Bruno E Correia, William R Schief, James E Crowe

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Explore antibody repertoire in the era of AI.Acta biochimica et biophysica Sinica · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Science immunology · 2021
    Article
  8. Article
  9. Article
  10. Higher Binding Affinity andAllergy, asthma & immunology research · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

John T BatesDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Christopher J Keefer
Thomas J Utley
Bruno E Correia
William R Schief
James E Crowe
Vanderbilt University Medical Center · USInternational AIDS Vaccine Initiative · USScripps Research Institute · US

Funding

Pediatric Scientist Development Program (PSDP) [K12]K12HD000850 · NICHD · YALE UNIVERSITY · PI Sallie R. Permar · 1987 to 2026
$44.1M
NICHD NIH HHS K12 HD000850
6 · The paper itself

Abstract

The role of affinity in determining neutralizing potency of mAbs directed against viruses is not well understood. We investigated the kinetic, structural, and functional advantage conferred by individual naturally occurring somatic mutations in the Ab H chain V region of Fab19, a well-described neutralizing human mAb directed to respiratory syncytial virus. Comparison of the affinity-matured Ab Fab19 with recombinant Fab19 Abs that were variants containing reverted amino acids from the inferred unmutated ancestor sequence revealed the molecular basis for affinity maturation of this Ab. Enhanced binding was achieved through mutations in the third H chain CDR (HCDR3) that conferred a markedly faster on-rate and a desirable increase in antiviral neutralizing activity. In contrast, most somatic mutations in the HCDR1 and HCDR2 regions did not significantly enhance Ag binding or antiviral activity. We observed a direct relationship between the measured association rate (Kon) for F protein and antiviral activity. Modeling studies of the structure of the Ag-Ab complex suggested the HCDR3 loop interacts with the antigenic site A surface loop of the respiratory syncytial virus F protein, previously shown to contain the epitope for this Ab by experimentation. These studies define a direct relationship of affinity and neutralizing activity for a viral glycoprotein-specific human mAb.

Indexed as

MutationAmino Acid SequenceAntibodies, MonoclonalAntibodies, NeutralizingAntibodies, ViralAntibody AffinityAntibody SpecificityHumansImmunoglobulin Fab FragmentsImmunoglobulin Variable RegionKineticsModels, MolecularMolecular Docking SimulationNeutralization TestsProtein BindingProtein ConformationAntibodies, MonoclonalAntibodies, NeutralizingAntibodies, ViralF protein, human respiratory syncytial virusImmunoglobulin Fab FragmentsImmunoglobulin Variable RegionRecombinant ProteinsViral Fusion Proteins

Identifiers

PMID23455501
PMCPMC3608519
OpenAlexW1899877916

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.